Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1110537

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment the Government has made of the effectiveness of the implementation of the guidance entitled Items which should not be routinely prescribed in primary care: Guidance for CCGs.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	242690
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>We are informed by NHS England that in the period up to and including October 2018, spend on the 18 low priority medicines has fallen by £31.1 million from £133.6 million, compared to 2016/17. This represents a reduction of 23%.</p><p> </p><p>The volume of medicines prescribed reduced by 27% and the number of patients prescribed these medicines reduced by 32%.</p><p> </p><p>In addition, NHS England has worked with PrescQIPP and the NHS Business Services Authority to refine its assessment of the amount of money spent on over the counter medicines.</p><p> </p><p>In the 12 months to January 2019, the total National Health Service spend in England on over the counter medicines was £449.4 million. This was a saving on total spend of £25.9 million from the 12 months to January 2018, which was £475.3 million. This saving does not account for the potential impact to the NHS from a reduced number of general practitioner appointments, for which no assessment has been made.</p><p> </p><p>These savings will be reinvested into the NHS, ensuring patients can access high quality care now and in the future.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:04 answering member 4455 label Biography information for Seema Kennedy
tabling member	392 label Biography information for Sir Kevin Barron

1110538

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments: Prescription Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the guidance published by NHS England, Items which should not routinely be prescribed in primary care: Guidance for CCGs, what estimate his Department has made of the number of patients that have been refused prescriptions for over-the-counter medicines by their GP since the publication of that guidance.
tabling member constituency	Rother Valley
tabling member printed	Sir Kevin Barron
uin	242691
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Department has made no assessment of the number of patients refused prescriptions for over the counter medicines.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:58:58 answering member 4455 label Biography information for Seema Kennedy
tabling member	392 label Biography information for Sir Kevin Barron

1110551

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps is the Government taking to ensure timely access to maintenance medication for people with cancer.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	242692
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Department fully understands that maintaining access to cancer medication is vitally important to many people in this country.</p><p> </p><p>There is already a team within the Department that deals with medicine supply issues arising both in the community and hospitals. We have well established procedures to deal with medicine shortages, from whatever cause, and work closely with the Medicines and Healthcare products Regulatory Agency, the pharmaceutical industry, NHS England and others operating in the supply chain to help prevent shortages and to ensure that the risks to patients are minimised when they do arise.</p><p> </p><p>If we are aware of issues with cancer medications we work with national clinical experts to advise on management plans and ensure that appropriate information is provided to the National Health Service and specialist patient groups.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:58:08 answering member 4455 label Biography information for Seema Kennedy
tabling member	394 label Biography information for Mr Clive Betts

1110552

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the appraisal process for personalised treatments for small patient groups.
tabling member constituency	Sheffield South East
tabling member printed	Mr Clive Betts
uin	242693
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. Through its technology appraisal and highly specialised technologies programmes, NICE plays an important role in ensuring that patients are able to benefit from effective new treatments, including treatments for small numbers of patients. NICE has recommended a number of drugs for small patient populations through these programmes that are now routinely funded by the National Health Service for eligible patients.</p><p> </p><p>NICE periodically reviews its methods and processes to ensure that they keep pace with developments in science and healthcare. NICE will be carrying out a review of its technology appraisal and highly specialised technologies methods in 2019/20.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:57 answering member 4455 label Biography information for Seema Kennedy
tabling member	394 label Biography information for Mr Clive Betts

1110572

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Bowel Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timescale is for the introduction of the faecal immunochemical test for the bowel cancer screening programme in England.
tabling member constituency	Nottingham North
tabling member printed	Alex Norris
uin	242932
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The UK National Screening Committee advised that Faecal Immunochemical Test (FIT) is a more sensitive and accurate test than guaiac faecal occult blood test (FOBt), and that more bowel cancers could be detected, and recommended that FIT should replace the currently used FOB test.</p><p> </p><p>Full replacement of the current FOBt with FIT across all Hubs in the NHS Bowel Cancer Screening Programme is planned for summer 2019.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:59:51 answering member 4455 label Biography information for Seema Kennedy
tabling member	4641 label Biography information for Alex Norris

1110582

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Silica: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect on human health of exposure to silica dust; what (a) guidance and (b) legislative measures are in place to control human exposure to silica dust; and if he will make a statement.
tabling member constituency	West Bromwich East
tabling member printed	Tom Watson
uin	242745
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>Many studies have indicated that silica dust can be harmful when inhaled. In the United Kingdom, all workplaces must comply with the Control of Substances Hazardous to Health Regulations 2002, which sets a workplace exposure limit for silica. Occupational health and safety is under the remit of the Health and Safety Executive, who have issued guidance and advice to help employers manage risks and to raise awareness of the importance of controlling exposure to harmful materials at work which is available at the following link:</p><p> </p><p><a href="http://www.hse.gov.uk/pubns/indg463.pdf" target="_blank">http://www.hse.gov.uk/pubns/indg463.pdf</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 13:02:57 answering member 4455 label Biography information for Seema Kennedy
tabling member	1463 label Biography information for Lord Watson of Wyre Forest

1110596

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Asthma: Medical Equipment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to encourage the use of more environmentally-friendly inhalers.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	242727
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The Sustainable Development Unit, a joint NHS England and Public Health England unit, has established a cross sector working group on low carbon inhalers. A cross system approach is now being developed into a system wide implementation plan, with specific actions being delivered by individual members of the group. All actions are supporting progress towards or to exceed the NHS Long Term Plan commitment on low carbon inhalers. This will contribute to the overall National Health Service commitment in the Long Term Plan to reduce carbon emissions in line with the UK Climate Change Act.</p><p> </p><p>On 8 April 2019, the National Institute for Health and Care Excellence (NICE) published a patient decision aid to help people with asthma, alongside health professionals, to identify which inhalers could meet their needs and control their symptoms. Where several inhalers could be viable options, the decision aid helps clinicians and patients choose the more environmentally friendly option, with a lower carbon footprint. It is co-funded by the SDU.</p><p> </p><p>This is the first time NICE has included climate change impacts in any guidance. The decision aid also highlights the need for used devices to be returned to pharmacies for environmentally safe disposal.</p><p> </p><p>A link to NICE’s decision aid can be found at the following link:</p><p><a href="https://www.nice.org.uk/guidance/ng80/resources/inhalers-for-asthma-patient-decision-aid-pdf-6727144573" target="_blank">https://www.nice.org.uk/guidance/ng80/resources/inhalers-for-asthma-patient-decision-aid-pdf-6727144573</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:57:11 answering member 4455 label Biography information for Seema Kennedy
tabling member	1436 label Biography information for Paul Farrelly

1110783

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Ophthalmology
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 April 2019 to Question 239204 on Ophthalmology, whether the NHS Improvement impact assessment (a) covers changes affecting patient access to combined Minimally Invasive Glaucoma Surgery (MIGS) and cataract operation and (b) recognises the procedure as a common practice; and whether the new tariff price was assessed to cover cataract and MIGS as a single operation.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	242747
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>In considering the proposed prices for the 2019/20 national tariff, the ophthalmology Clinical Expert Working Group (EWG) specifically stated that minimally invasive glaucoma surgery (MIGS) and cataract activity are commonly done together and it would not usually be in the patient’s best interest to do them separately. The prices assigned to HRG BZ91 in the 2019/20 tariff cover cataract and MIGS as a single operation. The EWG and Royal College of Ophthalmology agreed that the BZ91 prices were appropriate, relative to the prices for other ophthalmology procedures.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 13:01:52 answering member 4455 label Biography information for Seema Kennedy
tabling member	1511 label Biography information for Lord Austin of Dudley

1110785

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Visual Impairment: Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 April 2019 to Question 239205 on Ophthalmology, if his Department will publish the (a) data and (b) analysis on which NHS Improvement based the assessment that indicates that Minimally Invasive Glaucoma Surgery (MIGS) is cheaper than other glaucoma procedures; and what the difference is in reference costs for MIGS and cataract operation since the last tariff prices were set.
tabling member constituency	Dudley North
tabling member printed	Ian Austin
uin	242748
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The current codes do not allow differentiation between minimally invasive glaucoma surgery (MIGS) and non-MIGS activity.</p><p> </p><p>In the development of each national tariff, NHS England and NHS Improvement undertakes an overall assessment of the impact of proposals. This includes consideration of change in expenditure on different types of care in ‘2019/20 National Tariff Payment System – A consultation notice: Impact assessment’. While this provides an overall assessment of impact, detailed feedback on proposed prices for individual Healthcare Resource Groups (units of healthcare) is sought from clinical Expert Working Groups (EWGs). EWGs are managed by the NHS Digital National Casemix Office and comprise clinicians representing specific specialities. This is to ensure that the published tariff supports clinical practice.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 13:00:52 answering member 4455 label Biography information for Seema Kennedy
tabling member	1511 label Biography information for Lord Austin of Dudley

1110804

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure a high level of up-take of the HPV vaccine throughout the country.
tabling member constituency	Livingston
tabling member printed	Hannah Bardell
uin	242896
answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>Coverage of the human papillomavirus (HPV) vaccine in teenage girls is high with nearly 84% receiving the full course of vaccine. Public Health England (PHE) developed a range of materials targeted at teenagers and their parents to provide information about the HPV vaccination programme to help them make an informed choice. Local immunisation providers should share this information and signpost teenagers and their parents to these materials when the offer of HPV vaccination is underway in schools. These materials can be viewed at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/collections/immunisation#human-papillomavirus-(hpv)-for-girls" target="_blank">https://www.gov.uk/government/collections/immunisation#human-papillomavirus-(hpv)-for-girls</a></p><p> </p><p>PHE also provides information and training materials for health professionals to ensure they can adequately respond to queries or concerns. These training materials can be viewed at the following link:</p><p> </p><p><a href="https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter-18a" target="_blank">https://www.gov.uk/government/publications/human-papillomavirus-hpv-the-green-book-chapter-18a</a></p><p> </p><p>In addition, PHE has also worked closely with several charities such as Jo’s Cervical Cancer Trust and the Teenage Cancer Trust to develop lesson plans for schools to use to teach young people about cervical cancer and the HPV vaccine. These can be seen at the following links:</p><p> </p><p><a href="https://www.jostrust.org.uk/information-healthcare-professionals/information-teachers" target="_blank">https://www.jostrust.org.uk/information-healthcare-professionals/information-teachers</a></p><p> </p><p><a href="https://www.teenagecancertrust.org/about-us/what-we-do/cancer-awareness/resources#cervicalcancer" target="_blank">https://www.teenagecancertrust.org/about-us/what-we-do/cancer-awareness/resources#cervicalcancer</a></p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:53:23 answering member 4455 label Biography information for Seema Kennedy
tabling member	4486 label Biography information for Hannah Bardell